Vineet Laboratories Company Secretary resigns effective May 29

1 min read     Updated on 30 May 2026, 04:59 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Vineet Laboratories Limited announced the resignation of Mr. Ramesh Kumar Bandari from the post of Company Secretary and Compliance Officer effective May 29, 2026. The resignation, attributed to personal reasons, was disclosed under Regulation 30 of the SEBI (LODR) Regulations, 2015.

powered bylight_fuzz_icon
41642969

*this image is generated using AI for illustrative purposes only.

Vineet Laboratories Limited announced that Mr. Ramesh Kumar Bandari has resigned from the post of Company Secretary and Compliance Officer effective May 29, 2026, due to personal reasons. The disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Consequently, Mr. Bandari has ceased to be Key Managerial Personnel under Section 203 of the Companies Act, 2013.

The resignation was communicated to the stock exchanges via a letter dated May 29, 2026. In his resignation letter, Mr. Bandari cited pre-occupation and personal obligations as the reasons for stepping down. He requested the Board to take the necessary steps, including intimating the Stock Exchanges and filing the required forms with the Registrar of Companies.

Details of the Change

The company provided the following details regarding the change in key managerial personnel as per Regulation 30 read with Schedule III of the Listing Regulations and SEBI Circular No. HO/49/14/14(7)2025-CFD-P0D2/I/3762/2026 dated January 30, 2026.

S. No Details of Events Information
1 Reason for change Resignation of Mr. Ramesh Kumar Bandari (A24519) as Company Secretary & Compliance Officer due to personal reasons
2 Date of cessation Relieved from services with effect from May 29, 2026
3 Brief profile Not Applicable
4 Disclosure of relationships Not Applicable

The filing was signed by Managing Director Gaddam Venkata Ramana on behalf of Vineet Laboratories Limited.

Historical Stock Returns for Vineet Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+1.55%-0.49%-8.57%-4.21%+10.34%-10.75%

Who will be appointed as the interim or permanent replacement for the Company Secretary and Compliance Officer?

How will the resignation impact the company's ongoing compliance and regulatory filing processes?

Will the change in key managerial personnel affect the company's strategic initiatives or governance policies?

Vineet Laboratories Reports Q3FY26 Profit of ₹85.07 Lakh, Board Approves Results

2 min read     Updated on 16 Feb 2026, 03:44 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Vineet Laboratories achieved a remarkable financial turnaround in Q3FY26 with net profit of ₹85.07 lakh compared to previous year loss of ₹570.70 lakh, despite revenue declining to ₹1,564.83 lakh. The Board of Directors approved quarterly results and strategic equipment investments for the new production facility during their February 14, 2026 meeting.

powered bylight_fuzz_icon
32762473

*this image is generated using AI for illustrative purposes only.

Vineet laboratories Limited has reported a significant turnaround in its Q3FY26 financial performance, posting a net profit of ₹85.07 lakh compared to a substantial loss of ₹570.70 lakh in the corresponding quarter of the previous fiscal year. The pharmaceutical company's Board of Directors approved these unaudited standalone financial results for the quarter and nine months ended December 31, 2025, during their meeting held on February 14, 2026.

Board Meeting Outcomes and Regulatory Compliance

The Board meeting, which commenced at 11:30 AM and concluded at 3:40 PM on February 14, 2026, addressed multiple strategic decisions beyond financial result approval. The company has submitted its quarterly results under Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to both BSE Limited (Scrip Code: 543298) and National Stock Exchange of India Limited (Scrip Code: VINEETLAB).

Board Decision Details
Financial Results Approval Q3FY26 and nine-month results with auditor review
Equipment Payments Quality Control and Purified RO Water equipment
Facility Purpose New production facility installation
Meeting Duration 11:30 AM to 3:40 PM

Financial Performance Overview

The company's quarterly financial metrics demonstrate a mixed performance with profitability recovery despite revenue challenges:

Metric Q3FY26 Q3FY25 Change
Revenue from Operations ₹1,564.83 lakh ₹1,809.93 lakh -13.5%
Total Income ₹1,569.59 lakh ₹1,813.19 lakh -13.4%
Total Expenses ₹1,487.79 lakh ₹2,380.59 lakh -37.5%
Net Profit/(Loss) ₹85.07 lakh (₹570.70 lakh) Positive turnaround
Basic EPS ₹0.92 (₹6.19) Positive turnaround

Nine-Month Performance Analysis

For the nine-month period ended December 31, 2025, Vineet Laboratories achieved remarkable improvement in profitability:

Parameter 9M FY26 9M FY25 Variance
Revenue from Operations ₹4,050.96 lakh ₹6,091.86 lakh -33.5%
Net Profit/(Loss) ₹38.56 lakh (₹966.61 lakh) Positive turnaround
Basic EPS ₹0.42 (₹10.48) Significant improvement

Equipment Investments and Strategic Approvals

The Board ratified advances and approved payments to vendors for Quality Control equipment and Purified RO Water equipment made in February 2026. These investments are designated for installation in the company's new production facility, which was previously mentioned in the Rights Issue Letter of Offer dated December 17, 2025. The equipment purchases represent strategic investments in expanding manufacturing capabilities.

Auditor Review and Compliance

NSVR & Associates LLP, the company's statutory auditors, issued an unqualified review report on the quarterly results. The financial results have been prepared in accordance with Indian Accounting Standards and comply with SEBI regulations. The results are available on the company's website at www.vineetlabs.co.in and on BSE and NSE platforms for stakeholder access.

Historical Stock Returns for Vineet Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+1.55%-0.49%-8.57%-4.21%+10.34%-10.75%

More News on Vineet Laboratories

1 Year Returns:+10.34%